If your spider-senses are tinglin’, it’s because The Amazing Spider-Man™video game has web-slung its way onto retail store shelves today in North America, and will be available in Europe on June 29th. From Activision Publishing, Inc., a wholly owned subsidiary of Activision Blizzard, Inc. (Nasdaq: ATVI), and Marvel Entertainment, The Amazing Spider-Man video game serves as an epilogue story to this summer’s upcoming blockbuster feature film, heralding Spidey’s return to a free-roaming Manhattan as players take the role of a young Peter Parker discovering his newfound powers and Super Hero responsibilities. The Amazing Spider-Man video game is available on the Xbox 360® video game and entertainment system from Microsoft, PlayStation®3 computer entertainment system, the Wii™ system from Nintendo, Nintendo 3DS™ and Nintendo DS™ handheld systems.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56937-activision-marvel-the-amazing-spider-man-new-video-game
Activision Blizzard, Inc., the largest third-party interactive entertainment software publisher (Nasdaq: ATVI), and Tencent Holdings Limited, a leading Internet services provider in China (SEHK: 00700), today announced a strategic relationship to bring Call of Duty Online to Chinese game players.
Call of Duty Online has been in development by Activision Publishing, Inc., a wholly owned subsidiary of Activision Blizzard, for approximately two years. Under the multi-year agreement with Activision Publishing, Tencent has the exclusive license to operate Call of Duty Online in mainland China. The game is free-to-play and monetized through the sales of in-game items.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56961-activision-and-tencent-bring-call-of-duty-franchise-to-china
Dungeon Rampage, the online game from developer and publisher Rebel Entertainment, an operating business of IAC (NASDAQ: IACI), officially launches today with new and expanded free-to-play content on Facebook Platform, dedicated site DungeonRampage.com and online gaming portal Kongregate.com.
To celebrate the launch, Rebel Entertainment is hosting a “Founders’ Week,” in which players can sign up on any platform between now and September 11 to receive special in-game bonuses, including an exclusive character style, customizable profile add-ons and more.
To view Multimedia News Release, go to http://www.multivu.com/mnr/57854-rebel-entertainment-dungeon-rampage-online-arcade-style-multiplayer-game
WebMD Health Corp. (NASDAQ: WBMD), the leading source of health information, today announced its new WebMD Pain Coach™ for iPhone, a unique free mobile application for consumers and patients living with chronic pain. As the leader in mobile health, WebMD provides trusted health information anytime and anywhere with its mobile web and applications for consumers and physicians. The new WebMD Pain Coach™ app builds on WebMD’s market-leading mobile applications through a holistic approach that helps users create a balanced lifestyle.
To view Multimedia News Release, go to http://www.multivu.com/mnr/57975-webmd-launches-unique-new-mobile-app-for-those-living-with-chronic-pain
The Brown Mackie College system of schools (“Brown Mackie College”), a college of Education Management Corporation (NASDAQ:EDMC), is adopting technology into education, converting students at its 28 schools nationwide to 100 percent e-textbooks and Apple iPad technology. Through the college’s Student Advantage Program, each incoming student will receive an iPad with the applications and textbooks necessary to make the technology a key part of their overall educational experience.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59095-brown-mackie-college-system-conversion-to-e-textbooks-ipad-nationwide
To most technologists, cloud computing is about applications, servers, storage and connectivity. To Texas Instruments Incorporated (TI) (NASDAQ: TXN) it means much more. Today, TI is unveiling a BETTER way to cloud with six new multicore System-on-Chips (SoCs). Based on its award winning KeyStone architecture, TI’s SoCs are designed to revitalize cloud computing, inject new verve and excitement into pivotal infrastructure systems and, despite their feature rich specifications and superior performance, actually reduce energy consumption.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54044-texas-instruments-keystone-multicore-socs-revitalize-cloud-applications
Almirall, S.A. (ALM:MC) and Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) announced today that the European Commission has granted marketing authorization to Constella® (linaclotide 290mcg) for the symptomatic treatment of moderate to severe Irritable Bowel Syndrome with Constipation (IBS-C) in adults . This approval follows the positive recommendation received from the European Committee for Medicinal Products for Human Use (CHMP) in September.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58658-almirall
As a new survey conducted online by Harris Interactive on behalf of Nutrisystem among over 3,000 U.S adults in December, indicates more than half of Americans (54 percent) are planning to make New Year’s resolutions to lose weight. Nutrisystem (NASDAQ: NTRI), the leading provider of home-delivered weight loss meal plans, is gearing up to help them succeed in keeping those resolutions.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59643-nutrisystem-survey-weight-loss-new-year-s-resolutions
Symmetricom®, Inc. (NASDAQ: SYMM), a worldwide leader in precision time and frequency technologies, today announced a new timing solution that meets the stringent microsecond accuracy requirements of Smart Grid substations. Specifically designed for substation operations, such as wide area measurement systems, traveling wave fault locators and sampled values, the Symmetricom SyncServer SGC-1500 Smart Grid Clock offers power utility companies accurate, secure and reliable timing and synchronization for their mission-critical operations. This means companies like Pacific Gas & Electric (PG&E) will be able to mitigate outages with real-time monitoring for grid stress, frequency instability, voltage instability and reliability margins.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60168-symmetricom-next-generation-syncserver-sgc-1500-smart-grid-clock-utilities
WebMD Health Corp. (Nasdaq: WBMD), the leading source of health information, announced today its new WebMD Allergy app for the iPhone, an innovative new mobile resource that empowers consumers to take control of their allergies. It is the first free app to provide allergy sufferers with personalized location-based allergy condition forecasts in combination with WebMD’s trusted information and insights. WebMD Allergy is further personalized with optional mobile push notifications that warn when allergen levels are high, enabling app users to proactively manage their allergy conditions.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60044-webmd-introduces-new-allergy-app-for-iphone
Solta Medical, Inc. (Nasdaq: SLTM), the global market leader in aesthetic skin treatments, today announced the launch of the Simply Smart Rewards Program for Clear + Brilliant laser treatments, the first-ever patient loyalty program in aesthetic laser skin resurfacing.
Clear + Brilliant and Clear + Brilliant Perméa treatments have been shown to help improve skin tone, texture and other subtle signs of aging. The precise laser energy has allowed most consumers to experience immediate and progressive results that last for months, but vary by age, skin condition and how they protect their skin. The treatment takes about 20 minutes, is safe for all skin types and is suitable for men and women.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61178-solta-medical-launches-clear-brilliant-simply-smart-rewards-program
Raptor Pharmaceutical Corp. (“Raptor” or the “Company”) (Nasdaq: RPTP), today announced that the U.S. Food and Drug Administration (FDA) has approved PROCYSBI™ (cysteamine bitartrate) delayed release capsules for the treatment of nephropathic cystinosis in adults and children 6 years and older. In a Phase 3 study, PROCYSBI showed consistent cystine depletion over the full 12-hour dosing period. Sustained levels of cysteamine have not historically been achieved in the majority of patients in this population. Studies have shown that sustained cystine depletion in patients may significantly delay disease progression, including kidney dysfunction, dialysis, kidney transplant, organ failure and premature death.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61338-raptor-pharmaceutical-procysbi-fda-approval-nephropathic-cystinosis
